Disc Medicine, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWatertown, MA
US patents3
SAM.gov UEIC5L9Q68Y89M3
CAGE code17HA3
Incorporated inDE
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
3 US patents granted 2023–2025, 3 of them in the five years to SEP 2025.
Pharmaceuticals 2Organic fine chemistry 1
- Matriptase 2 inhibitors and uses thereofUS 12,428,415 · granted SEP 30, 2025
- Anti-hemojuvelin (HJV) antibodies for treating myelofibrosisUS 12,365,729 · granted JUL 22, 2025
- Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitorsUS 11,813,257 · granted NOV 14, 2023
Granted to Disc Medicine, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Disc Medicine, INC. | Watertown | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.